コンテンツへスキップ
Merck
  • Application of palladium-mediated (18)F-fluorination to PET radiotracer development: overcoming hurdles to translation.

Application of palladium-mediated (18)F-fluorination to PET radiotracer development: overcoming hurdles to translation.

PloS one (2013-04-05)
Adam S Kamlet, Constanze N Neumann, Eunsung Lee, Stephen M Carlin, Christian K Moseley, Nickeisha Stephenson, Jacob M Hooker, Tobias Ritter
要旨

New chemistry methods for the synthesis of radiolabeled small molecules have the potential to impact clinical positron emission tomography (PET) imaging, if they can be successfully translated. However, progression of modern reactions from the stage of synthetic chemistry development to the preparation of radiotracer doses ready for use in human PET imaging is challenging and rare. Here we describe the process of and the successful translation of a modern palladium-mediated fluorination reaction to non-human primate (NHP) baboon PET imaging-an important milestone on the path to human PET imaging. The method, which transforms [(18)F]fluoride into an electrophilic fluorination reagent, provides access to aryl-(18)F bonds that would be challenging to synthesize via conventional radiochemistry methods.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
パロキセチン 塩酸塩 ヘミ水和物, ≥98% (HPLC), powder
Supelco
Paroxetine maleate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
パロキセチン マレイン酸塩, ≥98% (HPLC), solid
パロキセチン 塩酸塩 ヘミ水和物, European Pharmacopoeia (EP) Reference Standard
システム適合性用パロキセチン, European Pharmacopoeia (EP) Reference Standard